Drug Safety Information for ERYTHROCIN (Erythromycin lactobionate)

Adverse Drug Reactions for ERYTHROCIN* (Erythromycin lactobionate)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with ERYTHROCIN
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Pyrexia27
2Pneumonia26
3Nausea*17
4Condition aggravated16
5Vomiting*15
6Interstitial lung disease15
7Hepatic function abnormal14
8Drug ineffective14
9Drug interaction14
10Respiratory failure14
11Diarrhoea*12
12Eye discharge12
13Chest pain11
14Alanine aminotransferase increased11
15Convulsion11
16Dyspnoea11
17Platelet count decreased11
18Pain10
19Blood pressure decreased10
20Cardiac failure9

* This side effect also appears in "Top 10 Side Effects of ERYTHROCIN " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking ERYTHROCIN
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Product used for unknown indication100
2Pneumonia86
3Prophylaxis50
4Bronchitis chronic48
5Chronic sinusitis36
6Emphysema35
7Ophthalmia neonatorum25
8Bronchiolitis25
9Antibiotic prophylaxis24
10Chronic obstructive pulmonary disease23

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for ERYTHROCIN

Total Reports Filed with FDA: 1660


Number of FDA Adverse Event Reports by Patient Age for ERYTHROCIN

Total Reports Filed with FDA: 1660*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Erythromycin lactobionate (Erythrocin)

Charts are based on 1660 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and ERYTHROCIN Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on ERYTHROCIN's side effects.